Effect of Postoperative Xylazine Administration on
Cardiopulmonary Function and Recovery Quality After
Isoflurane Anesthesia in Horses
Keila K. Ida
1
, DVM, Msc, Denise T. Fantoni
1
, DVM, PhD, Bruna T. Ibiapina
2
, DVM,
Maria‐Teresa M. R. Souto
3
, DVM, Msc, André L. V. Zoppa
3
, DVM, PhD, Luis Claudio L. C. Silva
3
, DVM, PhD,
and Aline M. Ambrósio
3
, DVM, PhD
1
Laboratório de Investigação Médica LIM‐08, Anestesiologia, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, Brazil ,
2
Hospital
Veterinário, Faculdade de Medicina Veterinária e Zootecnia (FMVZ), USP, São Paulo, Brazil and
3
Departamento de Cirurgia, FMVZ, USP, São Paulo,
Brazil
Corresponding Author
Dr. Keila K. Ida, DVM, Msc, Faculdade de
Medicina, Laboratório de Investigação
Médica LIM‐08, Anestesiologia,
Universidade de São Paulo, Av. Doutor
Arnaldo, 455, 2° andar, sala 2120, Cerqueira
César, 01246‐903, São Paulo, SP, Brazil.
E‐mail: keilaida@usp.br
Submitted July 2011
Accepted December 2011
DOI:10.1111/j.1532-950X.2013.12050.x
Objective: To evaluate equine cardiopulmonary function and recovery quality after
administration of 0.25 or 0.50 mg/kg xylazine intravenously (IV) during recovery.
Study Design: Randomized, blinded, prospective, clinical study.
Animals: Horses (n ¼ 20).
Methods: During recovery after 3 hours of isoflurane anesthesia for arthroscopic
surgery, horses were administered either 0.25 mg/kg (G25, n ¼ 10) or 0.50 mg/kg
(G50, n ¼ 10) xylazine intravenously. Vital signs and arterial blood samples were
obtained during recovery before sedation (baseline), 5, 10, 20, 30, and 45 minutes after
xylazine and 30 minutes after standing. The quality of recovery scores ranged from 10
to 72 (10 ¼ best, 72 ¼ worst).
Results: G25 horses recovered faster (mean SD, 33 5 min) than G50 horses (50
7 min, P < .0001). Mean maximal decrease in arterial oxygen tension was 55 11 mmHg
in G25 (at 10 minutes; P < .05) and 54 7 mmHg in G50 (at 20 minutes; P < .01). G25
group had a total recovery score (23 [range 18–29]) and number of attempts to stand (4 2)
greater than the G50 group (18 [10–23] and 1 1, respectively; P < .001).
Conclusions: Both doses of xylazine promoted a moderate and transient hypoxemia
during recovery; however, the 0.5 mg/kg dose produced a longer and improved quality
of recovery from anesthesia.
INTRODUCTION
Isoflurane is an inhalant anesthetic with a low blood‐gas solubility
coefficient that is often associated with a rapid recovery from
nonsurgical procedures in horses.
1
Recovery from surgical
procedures is described as ataxic and agitated with multiple
attempts to stand.
2–4
A short recovery time from anesthesia in
horses is associated with poor recovery quality and numerous
attempts to stand, which may increase complications.
1–6
Excitement is a major consideration during recovery from
anesthesia in horses.
5
Horses may attempt to stand as
consciousness is regained despite inappropriate muscle
strength or incoordination.
7
Generally, these early attempts
to stand are not successful, and they are associated with
complications, including fractures, joint dislocations, lacer-
ations and wound dehiscence.
4,8–11
Administration of alpha‐2 agonists during recovery from
anesthesia improves recovery quality.
5
The appropriate sedative
and analgesic effects reduce anxiety, increase recumbency times,
and prevent early attempts to stand.
9
Xylazine is the most
commonly used alpha‐2 agonist for this purpose because a low
dose induces shorter recoveries and less cardiovascular and
respiratory depression than romifidine and detomidine at
equipotent doses.
5,12,13
At lower doses, additional sedation may
be required because a single low dose may not prevent early
attempts to stand.
14
However, the safety of larger doses of xylazine
during recovery from isoflurane anesthesia in horses is unknown.
Our purpose was to evaluate recovery quality and cardiopulmo-
nary function after administration of 0.25 and 0.50 mg/kg
xylazine during recovery from isoflurane anesthesia in horses.
MATERIALS AND METHODS
Horses
The Bioethical Committee (Protocol number 1774/09)
approved this study. After obtaining client consent, mixed‐
Presented in part as an abstract at the 9th Brazilian Meeting of
Veterinary Anesthesiology, Goiânia, Brazil, November 4–6,
2009.
Veterinary Surgery 9999 (2013) 1–8 © Copyright 2013 by The American College of Veterinary Surgeons 1